The analgesic efficacy of transversus abdominis plane block after abdominal surgery: a prospective randomized controlled trial.
John G McDonnell, Brian O'Donnell, Gerard Curley...
https://pubmed.ncbi.nlm.nih.gov/17179269Actively Recruiting
Led by University of Tennessee · Updated on 2026-03-11
120
Participants Needed
1
Research Sites
N/A
Total Duration
U
University of Tennessee
Lead Sponsor
R
Regional One Health
Collaborating Sponsor
Researchers are evaluating how intraoperative transversus abdominis plane (TAP) blocks affect the amount of opioid pain medication needed after cesarean delivery during complex obstetric surgery. This study focuses on whether using bupivacaine in TAP blocks can reduce opioid use and improve pain control following surgery. The trial aims to fill gaps in understanding the role of TAP blocks specifically for high-risk or complicated cesarean deliveries. Participants are randomly assigned to one of two groups: one receives a TAP block with 0.5% bupivacaine mixed with saline, and the other receives a placebo TAP block with saline only. The TAP blocks are applied during surgery, and the study compares opioid consumption and pain outcomes between these groups. The trial uses a quadruple-blind design to ensure unbiased results. During the study, researchers will track opioid pain medication usage between 24 and 48 hours after surgery as the primary outcome. They will also look at opioid use within the first 24 hours and up to one week, assess daily living activities after one week, and monitor unplanned postoperative visits for six months. Additional data on patients' geographic regions will be collected to explore diversity and inclusion. Participants' pain, opioid use, and recovery will be carefully monitored throughout the study period, which lasts up to six months post-surgery.
CONDITIONS
COMFORT Trial: Complex Obstetric Management With Focused Regional Transversus Abdominis Plane Block
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of surgery
Participants undergo complex cesarean delivery surgery during which an intraoperative TAP block with either bupivacaine or placebo is administered to manage postoperative pain.
1 surgical visit (in-person)
Duration - Up to 6 months post-surgery
Participants are monitored for postoperative pain medication use, functional recovery, and any unplanned postoperative visits over several weeks to months after surgery.
Multiple follow-up visits including assessments at 24 hours, 48 hours, 1 week, and up to 6 months postoperatively
Total: 1 location
1
Regional One Health
Memphis, Tennessee, United States, 38103
Actively Recruiting
M
Michael VanDillen Fellow physician, PI of study, MD
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
John G McDonnell, Brian O'Donnell, Gerard Curley...
https://pubmed.ncbi.nlm.nih.gov/17179269N Johns, S O'Neill, N T Ventham...
https://pubmed.ncbi.nlm.nih.gov/22632762Gali Garmi, Mark Parasol, Noah Zafran...
https://pubmed.ncbi.nlm.nih.gov/36378307F W Abdallah, S H Halpern, C B Margarido
https://pubmed.ncbi.nlm.nih.gov/22907337